Role of surgery in the treatment of liver metastases from gastric cancer.
- Author:
Yulong HE
1
Author Information
1. Department of Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China. YLH@medmail.com.cn.
- Publication Type:Journal Article
- MeSH:
Adenocarcinoma;
Humans;
Liver Neoplasms;
secondary;
surgery;
Stomach Neoplasms;
pathology;
Survival Rate
- From:
Chinese Journal of Gastrointestinal Surgery
2014;17(2):105-107
- CountryChina
- Language:Chinese
-
Abstract:
The development of liver metastases is a fatal event for gastric cancer patients, and remains a major cause of cancer-related death. Many studies showed that the 5-year survival rate is as low as about 10% in these cases. The management of liver metastases from gastric adenocarcinoma remains controversial. The different therapeutic modalities used are surgery, radiofrequency ablation, hepatic arterial infusion and palliative gastrectomy. Surgery is a good indication for single liver metastasis of gastric carcinoma less than 5 cm and not associated with another extra-hepatic metastasis. In this article we discuss the role of surgery in the treatment of liver metastases from gastric cancer.
